References
- Cao Y, Tan A, Gao F, et al (2009). A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer. Int J Colorectal Dis, 24, 677-85. https://doi.org/10.1007/s00384-009-0655-9
- Choi KH, Park SM, Lee K, et al (2013). Prevalence, awareness, control, and treatment of hypertension and diabetes in Korean cancer survivors: a cross-sectional analysis of the fourth and fifth Korea national health and nutrition examination surveys. Asian Pac J Cancer Prev, 14, 7685-92. https://doi.org/10.7314/APJCP.2013.14.12.7685
- Daher IN, Yeh ET (2008). Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med, 5, 797-805. https://doi.org/10.1038/ncpcardio1375
- Havlik RJ, Yancik R, Long S, Ries L, Edwards B (1994). The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer, 74, 2101-6. https://doi.org/10.1002/1097-0142(19941001)74:7+<2101::AID-CNCR2820741718>3.0.CO;2-M
- Izzedine H, Ederhy S, Goldwasser F, et al (2009). Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol, 20, 807-15. https://doi.org/10.1093/annonc/mdn713
- Jain M, Townsend RR (2007). Chemotherapy agents and hypertension: a focus on angiogenesis blockade. Curr Hypertens Rep, 9, 320-8. https://doi.org/10.1007/s11906-007-0058-7
- Janssen-Heijnen MLG, Schipper RM, Razenberg PPA, Crommelin MA, Coebergh JWW (1998). Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer, 21, 105-13. https://doi.org/10.1016/S0169-5002(98)00039-7
- Janssen-Heijnen MLG, Smulders S, Lemmens VEPP, et al (2004). Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax, 59, 602-7. https://doi.org/10.1136/thx.2003.018044
- Ko C, Chaudhry S (2002). The need for a multidisciplinary approach to cancer care. J Surg Res, 105, 53-7. https://doi.org/10.1006/jsre.2002.6449
- Lopez-Encuentra A (2002). Comorbidity in operable lung cancer: a multicenter descriptive study on 2992 patients. Lung Cancer, 35, 263-9. https://doi.org/10.1016/S0169-5002(01)00422-6
- Pereira A, Garmendia ML, Alvarado ME, Albala C (2012). Hypertension and the risk of breast cancer in Chilean women: a case-control study. Asian Pac J Cancer Prev, 13, 5829-34. https://doi.org/10.7314/APJCP.2012.13.11.5829
- Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL., Jr (2004). Prognostic importance of comorbidity in a hospitalbased cancer registry. JAMA, 291 2441-7. https://doi.org/10.1001/jama.291.20.2441
- Ranpura V, Pulipati B, Chu D, Zhu X, Wu S (2010). Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis. Am J Hypertens, 23, 460-8. https://doi.org/10.1038/ajh.2010.25
- Satariano WA, Ragland DR (1994). The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med, 120, 104-10. https://doi.org/10.7326/0003-4819-120-2-199401150-00002
- Smith AW, Reeve BB, Bellizzi KM, et al (2008). Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev, 29, 41-56.
- Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005). Comorbidity and survival disparities among black and white patients with breast cancer. JAMA, 294, 1765-72. https://doi.org/10.1001/jama.294.14.1765
- Townsend RR (2006). Hypertension and cancer chemotherapies. In: Mohler ER, Townsend RR, editors. Advanced Therapy in Hypertension and Vascular Disease. Toronto, Canada: BC Decker; 2006. pp. 502-7.
- Yancik R, Wesley MN, Ries LA, et al (1998). Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer, 82, 2123-34. https://doi.org/10.1002/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.0.CO;2-W
- Yancik R, Wesley MN, Ries LAG, et al (2001). Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA, 285, 885-92. https://doi.org/10.1001/jama.285.7.885
- Yeh ETH (2006). Cardiotoxicity induced by chemotherapy and antibody therapy. Ann Rev Med, 57, 485-98. https://doi.org/10.1146/annurev.med.57.121304.131240
Cited by
- Screening for Patients with Non-small Cell Lung Cancer Who Could Survive Long Term Chemotherapy vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.647
- Pathologic Response During Chemo-radiotherapy and Variation of Serum VEGF Levels Could Predict Effects of Chemo-Radiotherapy in Patients with Esophageal Cancer vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1111
- Adoptive Immunotherapy for Small Cell Lung Cancer by Expanded Activated Autologous Lymphocytes: a Retrospective Clinical Analysis vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1487
- Clinical Investigation in Effect of Riboflavin Sodium Phosphate on Prevention and Treatment for Patients with Radiotherapy Related Esophagitis vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1525
- Inhibitory Effect of Curcumin on Invasion of Skin Squamous Cell Carcinoma A431 Cells vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2813
- Changes of Plasma Tumor Necrosis Factor α and C-Reactive Protein Levels in Patients with Hypertension Accompanied by Impaired Glucose Tolerance and their Clinical Significance vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3389
- Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.413
- A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.485